Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Mechanisms linking empagliflozin to cardiovascular and renal protection — Pasquale Perrone Filardi (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Mechanisms linking empagliflozin to cardiovascular and renal protection
Shared by
Aldo Maggioni
Mechanisms linking empagliflozin to cardiovascular and renal protection
Article
2017
en
Authors
+5 more
PF
Pasquale Perrone Filardi
AA
Angelo Avogaro
EB
Enzo Bonora
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2000
Endothelin Antagonists and Renal Protection
Ariela Benigni
,
Norberto Perico
,
Giuseppe Remuzzi
Article
1994
MECHANISMS OF ACQUIRED THYMIC UNRESPONSIVENESS TO RENAL ALLOGRAFTS
Mohamed H. Sayegh
,
Norberto Perico
,
Lorenzo Gallon
,
O Imberti
,
Wayne W. Hancock
,
Giuseppe Remuzzi
,
Charles B. Carpenter
Article
1994
MECHANISMS OF ACQUIRED THYMIC UNRESPONSIVENESS TO RENAL ALLOGRAFTS
Mohamed H. Sayegh
,
Norberto Perico
,
Lorenzo Gallon
,
O Imberti
,
Wayne W. Hancock
,
Giuseppe Remuzzi
,
Charles B. Carpenter
Article
2004
The way to cardio-renal protection in non-diabetic chronic nephropathies
Piero Ruggenenti
,
Giuseppe Remuzzi
,
Mario Negri
,
Giuseppe Remuzzi
Article
2019
Budget impact analysis of empagliflozin in T2D patients with a previous cardiovascular disease
Sergio Iannazzo
,
Aldo Maggioni
,
Edoardo Mannucci
Discussion(0)
No comments yet. Be the first to comment.